Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-08 · accession 0001209191-23-036248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-08 | KPTI | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $2.35 | -1,839 | 211.5K | -0.9% | -$4,322 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | S | D | 1,839 | $2.35 | 211,501 | D | — | — | (F2) Includes 2,653 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 28, 2023. |